Fig. 7From: Transcriptomic insight into salinomycin mechanisms in breast cancer cell lines: synergistic effects with dasatinib and induction of estrogen receptor βSal and Das together synergistically inhibited the BRCA1 pathway in the MDA-MB-468 cell line. A schematic diagram showing how the drug combination inhibited the BRAC1 pathway. The drug combination selectively suppressed the genes associated with the formation of complex B within the BRCA1 pathwayBack to article page